Can a glucose monitor and a phone call help control diabetes?

NCT ID NCT07587151

Completed Disease control Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether giving underserved patients with type 2 diabetes a continuous glucose monitor (CGM) plus monthly telehealth visits with a pharmacist helps them manage their blood sugar better. 46 adults with uncontrolled diabetes took part. Researchers compared those who got the CGM and telehealth to those who only got the CGM. The goal was to see if this approach is practical and effective in a community health center.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: continuous glucose monitor (CGM) and telehealth pharmacy visits
What this could lead to: If successful, this could show that adding remote pharmacy support to CGM helps underserved patients better control their diabetes.
What could go wrong: This is a small, completed pilot study with only 46 participants, so results may not apply to larger or different populations. It tested feasibility, not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Show contact details

Locations

University of Illinois College of Medicine Rockford

Rockford, Illinois, 61107, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.